Daewoong Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daewoong Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Hanmi Pharmaceutical., Company Limited
sales of 1.02 trillion Korean Won [US$862.55 million]
of which 78%
Kwang Dong Pharmaceutical Company Limited
(1.18 trillion Korean Won [US$1.00 billion]
of which 42%
was MRO), and
Daewoong Company Limited
(1.23 trillion Korean Won [US$1.05 billion]
of which 113%
was Medicinal Manufacturing & Selling).
During the year ended December of 2018, sales at
Daewoong Pharmaceutical Company Limited were 1.03 trillion Korean Won (US$875.68 million).
increase of 7.4%
versus 2017, when the company's sales were 960.31 billion Korean Won.
This was the fifth consecutive year of sales increases at Daewoong Pharmaceutical Company Limited
(and since 2013, sales have increased a total of 51%).
Sales of Medicine Manufacturing&sale saw an increase
9.8% in 2018, from
965.23 billion Korean Won to 1.06 trillion Korean Won.
Not all segments of Daewoong Pharmaceutical Company Limited experienced an increase in sales in 2018:
sales of Others fell 11.5% to 623.03 million Korean Won.
(However, this segment's sales were only a very small portion of the company's overall sales).
Daewoong Pharmaceutical Company Limited also experienced decreases in sales in
Prevention Diseases (down 1.1% to 6.02 billion Korean Won)